Cargando…

Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study

BACKGROUND AND OBJECTIVE: Mycophenolate mofetil is widely used in kidney transplant recipients. Mycophenolate mofetil is hydrolysed by blood esterases to mycophenolic acid (MPA), the active drug. Although MPA therapeutic drug monitoring has been recommended to optimise the treatment efficacy by the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riglet, François, Bertrand, Julie, Barrail-Tran, Aurélie, Verstuyft, Céline, Michelon, Hugues, Benech, Henri, Durrbach, Antoine, Furlan, Valérie, Barau, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691413/ https://www.ncbi.nlm.nih.gov/pubmed/33025511 http://dx.doi.org/10.1007/s40268-020-00319-y

Ejemplares similares

Dolutegravir Cerebrospinal Fluid Diffusion in HIV-1–Infected Patients with Central Nervous System Impairment
por: Gelé, Thibaut, et al.
Publicado: (2019)

Pharmacokinetics of Mycophenolic Acid after Intravenous Administration of Mycophenolate Mofetil to Healthy Cats
por: Slovak, J.E., et al.
Publicado: (2017)

Polyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy?
por: Dekeyser, Manon, et al.
Publicado: (2015)

Pharmacological Validation of Long-Term Treatment with Antiretroviral Drugs in a Model of SIV-Infected Non-Human Primates
por: Gelé, Thibaut, et al.
Publicado: (2022)

The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients
por: AbdElhalim, Mohamed S., et al.
Publicado: (2020)

Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN)
por: Ranganathan, Dwarakanathan, et al.
Publicado: (2019)

Pharmacokinetic Model Analysis of Supralingual, Oral and Intravenous Deliveries of Mycophenolic Acid
por: Gao, Xiuqing, et al.
Publicado: (2021)

Individualization of Mycophenolic Acid Therapy through Pharmacogenetic, Pharmacokinetic and Pharmacodynamic Testing
por: Winnicki, Wolfgang, et al.
Publicado: (2022)

Pharmacokinetics of mycophenolic acid and its effect on CD4(+) and CD8(+) T cells after oral administration of mycophenolate mofetil to healthy cats
por: Slovak, Jennifer E., et al.
Publicado: (2019)

Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation
por: Wei, Yinyi, et al.
Publicado: (2022)

Pharmacokinetics and tolerability of multiple‐day oral dosing of mycophenolate mofetil in healthy horses
por: Bello, Kaitlyn, et al.
Publicado: (2023)

Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients – a pilot study
por: Bremer, Sara, et al.
Publicado: (2009)

Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients
por: Sunder-Plassmann, Gere, et al.
Publicado: (2012)

Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation
por: Sobiak, Joanna, et al.
Publicado: (2015)

Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients
por: Zhang, Jun, et al.
Publicado: (2018)

Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: Cross-sectional study
por: Noreikaitė, Aurelija, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Immediate- and Modified-Release Mycophenolic Acid Preparations in Healthy Beagle Dogs
por: Klotsman, Michael, et al.
Publicado: (2021)

Pharmacokinetics of mycophenolic acid and its phenyl glucuronide metabolite in kidney transplant recipients with renal impairment
por: Kamińska, Jolanta, et al.
Publicado: (2012)

Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients
por: de Winter, Brenda C. M., et al.
Publicado: (2009)

Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers
por: Kim, Jae Hyun, et al.
Publicado: (2018)

Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients by Population Pharmacokinetic and Limited Sampling Strategies
por: Wang, Xipei, et al.
Publicado: (2021)

Treatment of Kimura disease with mycophenolate mofetil monotherapy
por: Shah, Kalee, et al.
Publicado: (2017)

Factors associated with Health-Related Quality of Life in Kidney Transplant Recipients in France
por: Mouelhi, Yosra, et al.
Publicado: (2018)

Mycophenolate-mofetil/mycophenolic-acid: COVID-19: 4 case reports
Publicado: (2021)

Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study
por: Djabarouti, Sarah, et al.
Publicado: (2010)

Mycophenolate mofetil toxicity mimicking acute cellular rejection in a small intestinal transplant
por: Apostolov, Ross, et al.
Publicado: (2017)

Exposure to Mycophenolate and Fatherhood
por: Midtvedt, Karsten, et al.
Publicado: (2017)

Mycophenolic Acid for Topical Immunosuppression in Vascularized Composite Allotransplantation: Optimizing Formulation and Preliminary Evaluation of Bioavailability and Pharmacokinetics
por: Feturi, Firuz G., et al.
Publicado: (2018)

Population Pharmacokinetics of Mycophenolic Acid in Renal Transplant Patients: A Comparison of the Early and Stable Posttransplant Stages
por: Wang, Peile, et al.
Publicado: (2022)

Pharmacokinetics and pharmacodynamics profiles of enteric‐coated mycophenolate sodium in female patients with difficult‐to‐treat lupus nephritis
por: Chariyavilaskul, Pajaree, et al.
Publicado: (2022)

Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant Recipients
por: Drevland, Ole Martin, et al.
Publicado: (2023)

Gut Microbiota-Mediated Pharmacokinetic Drug–Drug Interactions between Mycophenolic Acid and Trimethoprim-Sulfamethoxazole in Humans
por: Dukaew, Nahathai, et al.
Publicado: (2023)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Correction: Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study
por: Djabarouti, Sarah, et al.
Publicado: (2011)

Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
por: Fassbinder, Till, et al.
Publicado: (2015)

Impact of UGT1A9 Polymorphism on Mycophenolic Acid Pharmacokinetic Parameters in Stable Renal Transplant Patients
por: Mazidi, Talia, et al.
Publicado: (2013)

PReS-FINAL-2175: Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring
por: Woillard, JB, et al.
Publicado: (2013)

Influence of uridine diphosphate-glucuronosyltransferases (1A9) polymorphisms on mycophenolic acid pharmacokinetics in patients with renal transplant
por: Ciftci, H. S., et al.
Publicado: (2018)

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis
por: Mizaki, Tomoko, et al.
Publicado: (2023)

Mycophenolic Derivatives from Eupenicilliumparvum
por: Habib, Eman, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_qm4dl23g5j0jjioslt2ss4gm8q